These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 760213)

  • 21. Increased rates of myofibrillar protein breakdown in muscle-wasting diseases.
    Warnes DM; Tomas FM; Ballard FJ
    Muscle Nerve; 1981; 4(1):62-6. PubMed ID: 7231447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The L-arginine/NO pathway and homoarginine are altered in Duchenne muscular dystrophy and improved by glucocorticoids.
    Hörster I; Weigt-Usinger K; Carmann C; Chobanyan-Jürgens K; Köhler C; Schara U; Kayacelebi AA; Beckmann B; Tsikas D; Lücke T
    Amino Acids; 2015 Sep; 47(9):1853-63. PubMed ID: 26066683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Modifications in the elimination of creatine bodies in muscular dystrophy during vitamin B12 therapy].
    CORDA G
    Boll Soc Ital Biol Sper; 1952 Dec; 28(12):1935-7. PubMed ID: 13059130
    [No Abstract]   [Full Text] [Related]  

  • 24. Accurate quantification of dimethylamine (DMA) in human urine by gas chromatography-mass spectrometry as pentafluorobenzamide derivative: evaluation of the relationship between DMA and its precursor asymmetric dimethylarginine (ADMA) in health and disease.
    Tsikas D; Thum T; Becker T; Pham VV; Chobanyan K; Mitschke A; Beckmann B; Gutzki FM; Bauersachs J; Stichtenoth DO
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 851(1-2):229-39. PubMed ID: 17011246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 3-Methylhistidine excretion as an index of myofibrillar protein catabolism in neuromuscular disease.
    McKeran RO; Halliday D; Purkiss P; Royston P
    J Neurol Neurosurg Psychiatry; 1979 Jun; 42(6):536-41. PubMed ID: 469561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Duchenne muscular dystrophy. Effects of vitamin E administration on urinary luminescence].
    Pizarro M; Lissi E; Reyes J; Holmgren J
    Rev Med Chil; 1998 Oct; 126(10):1165-72. PubMed ID: 10030087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Dynamic studies on creatine and creatinine in urine in myopathies].
    LESNY I; DRECHSLER B
    Cas Lek Cesk; 1954 Apr; 93(16):433-5. PubMed ID: 13160994
    [No Abstract]   [Full Text] [Related]  

  • 28. Biochemical studies on muscular dystrophy. Serum and urine creatine, creatinine and aminoacids.
    el-Nabawy M; Sakr R; el-Hawary MF
    J Egypt Med Assoc; 1968; 51(11):949-63. PubMed ID: 5714513
    [No Abstract]   [Full Text] [Related]  

  • 29. [Research on the treatment of diseases accompanied by pathological creatinuria].
    de TONI E; REVERDITO E
    Arch Fr Pediatr; 1960; 17():705-14. PubMed ID: 13777398
    [No Abstract]   [Full Text] [Related]  

  • 30. Creatine and creatinine in tissues and urine of mice with hereditary muscular dystrophy.
    KANDUTSCH AA; RUSSELL AE
    Am J Physiol; 1958 Sep; 194(3):553-6. PubMed ID: 13571426
    [No Abstract]   [Full Text] [Related]  

  • 31. Proteins in the urine associated with Duchenne muscular dystrophy and other neuromuscular diseases.
    Frearson N; Taylor RD; Perry SV
    Clin Sci (Lond); 1981 Aug; 61(2):141-9. PubMed ID: 7261538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carnitine in Duchenne muscular dystrophy.
    Kobayashi T; Shinnoh N; Mawatari S
    Clin Chim Acta; 1979 Apr; 93(1):157-9. PubMed ID: 436293
    [No Abstract]   [Full Text] [Related]  

  • 33. Study of urinary excretion of nitrogenous compounds and their interrelationship in some diseased states.
    Bhambal SA; Sharma KS; Bhambal S
    Indian J Med Res; 1970 Oct; 58(10):1447-52. PubMed ID: 5501454
    [No Abstract]   [Full Text] [Related]  

  • 34. [Possible limitation or direct inhibition of pathological creatinuria in progressive muscular dystrophy by the use of large doses of anabolic steroids].
    DE TONI G
    Boll Soc Ital Biol Sper; 1959 Feb; 35(3):110-4. PubMed ID: 13638410
    [No Abstract]   [Full Text] [Related]  

  • 35. Dysbindin, syncoilin, and beta-synemin mRNA levels in dystrophic muscles.
    Wakayama Y; Matsuzaki Y; Yamashita S; Inoue M; Jimi T; Hara H; Unaki A; Iijima S; Masaki H
    Int J Neurosci; 2010 Feb; 120(2):144-9. PubMed ID: 20199207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein degradation in cultured skeletal muscle from Duchenne muscular dystrophy patients.
    Neville HE; Harrold S
    Muscle Nerve; 1985; 8(3):253-7. PubMed ID: 4058470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Attempt to influence creatinuria with a metabolite of glycolysis: fructose-1,6-diphosphate in primary myopathy].
    CORSINI F; MUSIANI S
    Clin Pediatr (Bologna); 1959 Jun; 41():446-54. PubMed ID: 13812097
    [No Abstract]   [Full Text] [Related]  

  • 38. [Neuromuscular diseases and metabolic disorders of creatine and creatinine, with special reference to biochemistry].
    Araki S; Matawari S
    Nihon Rinsho; 1969 Jan; 27(1):103-10. PubMed ID: 4890031
    [No Abstract]   [Full Text] [Related]  

  • 39. [Urinary amino acids in progressive muscular dystrophy and amyotonia congenita].
    BAUZA C
    Arch Pediatr Urug; 1959 Dec; 30():749-55. PubMed ID: 13797772
    [No Abstract]   [Full Text] [Related]  

  • 40. Role of diet lipids in the appearance of dystrophy and creatinuria in the vitamin E-deficient rat.
    Century B; Horwitt MK
    J Nutr; 1960 Nov; 72(3):357-67. PubMed ID: 13691931
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.